Remove Pharmaceutical Remove Portfolio Management Remove Valuation
article thumbnail

Conversation with the Portfolio Manager: Mid-Cap Growth Strategy

Brown Advisory

Conversation with the Portfolio Manager: Mid-Cap Growth Strategy achen Wed, 09/20/2017 - 16:43 Over time, the Brown Advisory small-cap growth team, led by Christopher Berrier and George Sakellaris, watched numerous successful investments compound and grow out of their investible universe. Second, we keep a keen eye on valuation.

article thumbnail

Conversation with the Portfolio Manager: Mid-Cap Growth Strategy

Brown Advisory

Conversation with the Portfolio Manager: Mid-Cap Growth Strategy. While both mid-cap portfolio managers believe their experience gives them an advantage, other factors set them apart as well. While valuation is critical to our approach, it occurs near the end of our process. Second, we keep a keen eye on valuation.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Transcript: Joel Tillinghast, Fidelity

The Big Picture

00:44:11 [Speaker Changed] Kathy would may have her own valuation, so, but I can’t replicate it myself. One, one of those big winners has been Cosmos Pharmaceutical, which is a discount drug store and food store and Southern Japan and 00:53:14 Their sg NA to sales, something like 14 or 15%. Cell phone service had stopped.

article thumbnail

Transcript: Vincent Aita of Cutter Capital

The Big Picture

And I think what I’m trying to imply is there’s a lot of informational value that’s already held within the valuations where these equities are trading that you can calculate, you know, a sense of the implied market probability of success for an opportunity for a company. There, 00:10:35 [Speaker Changed] There is.

article thumbnail

Transcript: Richard Bernstein

The Big Picture

Everybody wants to sell a company when they get a good valuation. Obviously, profits, very important to company valuation — BERNSTEIN: Absolutely. The other thing we do, Barry, is we group valuation as a sentiment indicator. So we do a lot of valuation work. BERNSTEIN: Correct. RITHOLTZ: Right. BERNSTEIN: Yes.

Economy 162
article thumbnail

Transcript: Tony Kim, Blackrock Active Technology

The Big Picture

Barry Ritholtz : This week on the podcast, another extra special guest, Tony Kim, is managing director at BlackRock, where he heads the fundamental equity technology group helping to oversee all of the active technology investments BlackRock makes. I must have worked for 30, 40 portfolio managers across four, four or five investment firms.